Morphosys Ag (MOR) has released an update.
MorphoSys AG has issued a notification of major holdings, indicating a change in voting rights as per the German Securities Trading Act. Royalty Pharma PLC, previously holding 3.91% of voting rights, has now reported a total of 0.00% in both direct and indirect voting rights. This significant shift in shareholder voting power has been officially announced by MorphoSys AG to ensure Europe-wide distribution of this critical information.
For further insights into MOR stock, check out TipRanks’ Stock Analysis page.